VaxDesign
Blood & Organ Banks · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8669 Commodity Cir, Orlando, Florida, 32...Phone Number
(407) 243-5600Website
www.vaxdesign.comRevenue
$7.3 MillionIndustry
About VaxDesign
VaxDesign's flagship technology, the MIMIC® System, helps predict the immune response of an individual or selected group to a drug candidate or vaccine candidate. VaxDesign is now a wholly-owned subsidiary of sanofi pasteur, the vaccines division of sanofi-aventis Group, a leading global pharmaceutical company that discovers, develops and distributes therapeutic solutions to improve the lives of everyone. As world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines, protecting against 20 infectious diseases.Explore more
VaxDesign Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to VaxDesign
Compare insights from companies similar to VaxDesign, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
VaxDesign Tech Stack
A closer look at the technologies used by VaxDesign
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VaxDesign
Sign Up For FreeTo access detailed company insights
VaxDesign's flagship technology, the MIMIC® System, helps predict the immune response of an individual or selected group to a drug candidate or vaccine candidate. VaxDesign is now a wholly-owned subsidiary of sanofi pasteur, the vaccines division of sanofi-aventis Group, a leading global pharmaceutical company that discovers, develops and distribut... Read More
